Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna Semaniakou"'
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2019)
Our understanding of the multiorgan pathology of cystic fibrosis (CF) has improved impressively during the last decades, but we still lack a full comprehension of the disease progression. Animal models have greatly contributed to the elucidation of s
Externí odkaz:
https://doaj.org/article/02cbb22790e84cc983706a569442e478
Autor:
Anna Semaniakou, Younes Anini, Valerie Chappe, Grayson Gould, Mehrsa Zahiremani, Jamie Paton, Roger P. Croll, Frederic Chappe, Audrey W. Li
Publikováno v:
Journal of Cystic Fibrosis. 20:154-164
Vasoactive Intestinal Peptide (VIP) is the major physiological agonist of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) chloride channel activity. VIP functions as a neuromodulator and neurotransmitter secreted by neurons innervating
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 20(5)
Vasoactive intestinal peptide (VIP), a 28-amino acid neuropeptide with potent anti-inflammatory, bronchodilatory and immunomodulatory functions, is secreted by intrinsic neurons innervating all exocrine glands, including the pancreas, in which it exe
Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients
Autor:
Antonios Kominakis, Theodosia Kazazoglou, Eva Kassi, Maria-Eleftheria Evangelopoulos, Amalia Sertedaki, Evangelia Charmandari, Anna Semaniakou, George P. Chrousos, Constantinos Sfagos, Paraskevi Moutsatsou
Publikováno v:
Journal of the Neurological Sciences. 363:165-169
Various specific human glucocorticoid receptor (NR3C1) gene polymorphisms have been described in multiple sclerosis (MS) patients and correlated with disease progression, susceptibility and aggressiveness. Herein, we investigated the presence of gene